Baracchini Edgardo Jr
Chief Business Officer at XNCR; Sr. VP of Business Development at METABASIS THERAPEUTICS INC
- Sold, on record
- $6M
- Dollars the filings state
- Form 4 sales
- 29
- Latest Aug 13, 2018
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 2
- Filed as an executive or holder
Companies
- XNCRXencor IncChief Business Officer
- METABASIS THERAPEUTICS INCSr. VP of Business Development
Sales by reason
0
Routine
6
Plan not stated
0
No plan
23
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- XNCR199,371 shares
- METABASIS THERAPEUTICS INC5,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- Aug 13, 2018Unusual
Sold 99.6% of their holdings
$2M50,000 shares at $40.16
- Mar 15, 2018Unusual
Sold 100% of their holdings
$1.2M40,000 shares at $30.89
- Mar 5, 2018Unusual
Sold 100% of their holdings
$592k20,000 shares at $29.59
- Feb 27, 2018Unusual
Sold 100% of their holdings
$593k20,000 shares at $29.64
- Feb 22, 2018Unusual
Sold 100% of their holdings
$210k8,069 shares at $26.00
- May 2, 2017Unusual
Sold 100% of their holdings
$275k10,568 shares at $26.01
- Apr 27, 2017Unusual
Sold 100% of their holdings
$24k904 shares at $26.04
- Mar 8, 2017Unusual
Sold 100% of their holdings
$46k1,821 shares at $25.00
- Sep 28, 2016Unusual
Sold 100% of their holdings
$254k10,000 shares at $25.35
- Sep 2, 2016Unusual
Sold 100% of their holdings
$211k10,000 shares at $21.06
10 of 29
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | May 16, 2024 | INMB | Director | AwardedOption (right to buy) | 12,500 | 12,500 | SEC | ||
| Feb 16, 2023 | Feb 21, 2023 | INMB | Director | AwardedOption (right to buy) | 35,000 | 35,000 | SEC | ||
| Mar 21, 2022 | Mar 23, 2022 | INMB | Director | AwardedOption (right to buy) | 35,000 | 35,000 | SEC | ||
| Jun 22, 2021 | Jun 24, 2021 | INMB | Director | AwardedOption (right to buy) | 19,025 | 19,025 | SEC | ||
| Jan 19, 2021 | Jan 21, 2021 | INMB | Director | AwardedOption (right to buy) | 15,975 | 15,975 | SEC | ||
| Nov 25, 2019 | Nov 27, 2019 | INMB | Director | AwardedOption | 108,000 | 108,000 | SEC | ||
| Aug 13, 2018 | Aug 13, 2018 | XNCR | Chief Business Officer | Sold | 50,000 | $40.16 | $2M | 207 | SEC |
| Aug 13, 2018 | Aug 13, 2018 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 50,000 | 0 | SEC | ||
| Aug 13, 2018 | Aug 13, 2018 | XNCR | Chief Business Officer | Exercised options | 50,000 | $11.05 | $553k | 12,941 | SEC |
| Mar 15, 2018 | Mar 16, 2018 | XNCR | Chief Business Officer | Sold | 40,000 | $30.89 | $1.2M | 0 | SEC |
| Mar 15, 2018 | Mar 16, 2018 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 40,000 | 41,809 | SEC | ||
| Mar 15, 2018 | Mar 16, 2018 | XNCR | Chief Business Officer | Exercised options | 40,000 | $0.59 | $24k | 40,000 | SEC |
| Mar 5, 2018 | Mar 5, 2018 | XNCR | Chief Business Officer | Sold | 20,000 | $29.59 | $592k | 0 | SEC |
| Mar 5, 2018 | Mar 5, 2018 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 20,000 | 81,809 | SEC | ||
| Mar 5, 2018 | Mar 5, 2018 | XNCR | Chief Business Officer | Exercised options | 20,000 | $0.59 | $12k | 10,000 | SEC |
| Feb 27, 2018 | Mar 1, 2018 | XNCR | Chief Business Officer | Sold | 20,000 | $29.64 | $593k | 0 | SEC |
| Feb 27, 2018 | Mar 1, 2018 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 20,000 | 101,809 | SEC | ||
| Feb 27, 2018 | Mar 1, 2018 | XNCR | Chief Business Officer | Exercised options | 20,000 | $0.59 | $12k | 20,000 | SEC |
| Feb 22, 2018 | Feb 23, 2018 | XNCR | Chief Business Officer | Sold | 8,069 | $26.00 | $210k | 0 | SEC |
| Feb 22, 2018 | Feb 23, 2018 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 8,069 | 121,809 | SEC | ||
| Feb 22, 2018 | Feb 23, 2018 | XNCR | Chief Business Officer | Exercised options | 8,069 | $0.59 | $5k | 8,069 | SEC |
| Jan 24, 2018 | Jan 26, 2018 | XNCR | Chief Business Officer | AwardedStock Option (right to buy) | 56,000 | 56,000 | SEC | ||
| May 2, 2017 | May 2, 2017 | XNCR | Chief Business Officer | Sold | 10,568 | $26.01 | $275k | 0 | SEC |
| May 2, 2017 | May 2, 2017 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 10,568 | 129,878 | SEC | ||
| May 2, 2017 | May 2, 2017 | XNCR | Chief Business Officer | Exercised options | 10,568 | $0.59 | $6k | 750 | SEC |
| Apr 27, 2017 | Apr 27, 2017 | XNCR | Chief Business Officer | Sold | 904 | $26.04 | $24k | 0 | SEC |
| Apr 27, 2017 | Apr 27, 2017 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 904 | 140,446 | SEC | ||
| Apr 27, 2017 | Apr 27, 2017 | XNCR | Chief Business Officer | Exercised options | 904 | $0.59 | $533 | 904 | SEC |
| Mar 8, 2017 | Mar 10, 2017 | XNCR | Chief Business Officer | Sold | 1,821 | $25.00 | $46k | 0 | SEC |
| Mar 8, 2017 | Mar 10, 2017 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 1,821 | 141,350 | SEC | ||
| Mar 8, 2017 | Mar 10, 2017 | XNCR | Chief Business Officer | Exercised options | 1,821 | $0.59 | $1k | 1,821 | SEC |
| Jan 30, 2017 | Feb 1, 2017 | XNCR | Chief Business Officer | AwardedStock Option (right to buy) | 70,000 | 70,000 | SEC | ||
| Sep 28, 2016 | Sep 28, 2016 | XNCR | Chief Business Officer | Sold | 10,000 | $25.35 | $254k | 0 | SEC |
| Sep 28, 2016 | Sep 28, 2016 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 10,000 | 143,171 | SEC | ||
| Sep 28, 2016 | Sep 28, 2016 | XNCR | Chief Business Officer | Exercised options | 10,000 | $0.59 | $6k | 10,000 | SEC |
| Sep 2, 2016 | Sep 6, 2016 | XNCR | Chief Business Officer | Sold | 10,000 | $21.06 | $211k | 0 | SEC |
| Sep 2, 2016 | Sep 6, 2016 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 10,000 | 153,171 | SEC | ||
| Sep 2, 2016 | Sep 6, 2016 | XNCR | Chief Business Officer | Exercised options | 10,000 | $0.59 | $6k | 10,000 | SEC |
| Aug 10, 2016 | Aug 11, 2016 | XNCR | Chief Business Officer | Sold | 2,500 | $21.83 | $55k | 0 | SEC |
| Aug 10, 2016 | Aug 11, 2016 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 2,500 | 163,171 | SEC | ||
| Aug 10, 2016 | Aug 11, 2016 | XNCR | Chief Business Officer | Exercised options | 2,500 | $0.59 | $1k | 2,500 | SEC |
| Aug 3, 2016 | Aug 5, 2016 | XNCR | Chief Business Officer | Sold | 4,528 | $20.00 | $91k | 0 | SEC |
| Jul 11, 2016 | Jul 13, 2016 | XNCR | Chief Business Officer | Sold | 1,250 | $18.13 | $23k | 4,528 | SEC |
| Jul 11, 2016 | Jul 13, 2016 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 1,250 | 165,671 | SEC | ||
| Jul 11, 2016 | Jul 13, 2016 | XNCR | Chief Business Officer | Exercised options | 1,250 | $0.59 | $738 | 5,778 | SEC |
| Jun 28, 2016 | Jun 30, 2016 | XNCR | Chief Business Officer | Sold | 1,250 | $15.10 | $19k | 4,528 | SEC |
| Jun 28, 2016 | Jun 30, 2016 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 1,250 | 166,921 | SEC | ||
| Jun 28, 2016 | Jun 30, 2016 | XNCR | Chief Business Officer | Exercised options | 1,250 | $0.59 | $738 | 5,778 | SEC |
| Apr 7, 2016 | Apr 11, 2016 | XNCR | Chief Business Officer | Sold | 3,750 | $15.00 | $56k | 4,528 | SEC |
| Apr 7, 2016 | Apr 11, 2016 | XNCR | Chief Business Officer | Exercised or settledStock Option (right to buy) | 3,750 | 168,171 | SEC |
Page 1
Sales and notices (29)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2018 | Aug 13, 2018 | XNCR | Chief Business Officer | Form 4 sale | 50,000 | $2M | 99.6% | Unusual | SEC |
| Mar 15, 2018 | Mar 16, 2018 | XNCR | Chief Business Officer | Form 4 sale | 40,000 | $1.2M | 100.0% | Unusual | SEC |
| Mar 5, 2018 | Mar 5, 2018 | XNCR | Chief Business Officer | Form 4 sale | 20,000 | $592k | 100.0% | Unusual | SEC |
| Feb 27, 2018 | Mar 1, 2018 | XNCR | Chief Business Officer | Form 4 sale | 20,000 | $593k | 100.0% | Unusual | SEC |
| Feb 22, 2018 | Feb 23, 2018 | XNCR | Chief Business Officer | Form 4 sale | 8,069 | $210k | 100.0% | Unusual | SEC |
| May 2, 2017 | May 2, 2017 | XNCR | Chief Business Officer | Form 4 sale | 10,568 | $275k | 100.0% | Unusual | SEC |
| Apr 27, 2017 | Apr 27, 2017 | XNCR | Chief Business Officer | Form 4 sale | 904 | $24k | 100.0% | Unusual | SEC |
| Mar 8, 2017 | Mar 10, 2017 | XNCR | Chief Business Officer | Form 4 sale | 1,821 | $46k | 100.0% | Unusual | SEC |
| Sep 28, 2016 | Sep 28, 2016 | XNCR | Chief Business Officer | Form 4 sale | 10,000 | $254k | 100.0% | Unusual | SEC |
| Sep 2, 2016 | Sep 6, 2016 | XNCR | Chief Business Officer | Form 4 sale | 10,000 | $211k | 100.0% | Unusual | SEC |
| Aug 10, 2016 | Aug 11, 2016 | XNCR | Chief Business Officer | Form 4 sale | 2,500 | $55k | 100.0% | Unusual | SEC |
| Aug 3, 2016 | Aug 5, 2016 | XNCR | Chief Business Officer | Form 4 sale | 4,528 | $91k | 100.0% | Unusual | SEC |
| Jul 11, 2016 | Jul 13, 2016 | XNCR | Chief Business Officer | Form 4 sale | 1,250 | $23k | 21.6% | Plan not stated | SEC |
| Jun 28, 2016 | Jun 30, 2016 | XNCR | Chief Business Officer | Form 4 sale | 1,250 | $19k | 21.6% | Plan not stated | SEC |
| Apr 7, 2016 | Apr 11, 2016 | XNCR | Chief Business Officer | Form 4 sale | 3,750 | $56k | 45.3% | Unusual | SEC |
| Dec 1, 2015 | Dec 3, 2015 | XNCR | Chief Business Officer | Form 4 sale | 1,250 | $20k | 100.0% | Unusual | SEC |
| Nov 25, 2015 | Nov 25, 2015 | XNCR | Chief Business Officer | Form 4 sale | 2,500 | $38k | 100.0% | Unusual | SEC |
| Sep 1, 2015 | Sep 3, 2015 | XNCR | Chief Business Officer | Form 4 sale | 1,250 | $21k | 100.0% | Unusual | SEC |
| Aug 3, 2015 | Aug 5, 2015 | XNCR | Chief Business Officer | Form 4 sale | 2,500 | $55k | 100.0% | Unusual | SEC |
| Jul 1, 2015 | Jul 1, 2015 | XNCR | Chief Business Officer | Form 4 sale | 2,500 | $56k | 100.0% | Unusual | SEC |
| Jun 15, 2015 | Jun 15, 2015 | XNCR | Chief Business Officer | Form 4 sale | 1,277 | $25k | 100.0% | Unusual | SEC |
| Jun 1, 2015 | Jun 1, 2015 | XNCR | Chief Business Officer | Form 4 sale | 1,250 | $23k | 100.0% | Unusual | SEC |
| May 15, 2015 | May 15, 2015 | XNCR | Chief Business Officer | Form 4 sale | 1,604 | $24k | 100.0% | Unusual | SEC |
| May 13, 2015 | May 14, 2015 | XNCR | Chief Business Officer | Form 4 sale | 200 | $3k | 11.1% | Plan not stated | SEC |
| Apr 29, 2015 | May 1, 2015 | XNCR | Chief Business Officer | Form 4 sale | 300 | $5k | 14.3% | Plan not stated | SEC |
| Apr 27, 2015 | Apr 29, 2015 | XNCR | Chief Business Officer | Form 4 sale | 100 | $2k | 4.5% | Plan not stated | SEC |
| Apr 24, 2007 | Apr 25, 2007 | METABASIS THERAPEUTICS INC | Sr. VP of Business Development | Form 4 sale | 4,300 | $35k | 58.8% | Unusual | SEC |
| Feb 26, 2007 | Feb 28, 2007 | METABASIS THERAPEUTICS INC | Sr. VP of Business Development | Form 4 sale | 700 | $6k | 8.7% | Plan not stated | SEC |
| Jun 26, 2006 | Jun 28, 2006 | METABASIS THERAPEUTICS INC | Sr. VP, Business Development | Form 4 sale | 500 | $4k | 35.9% | Unusual | SEC |